Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
(1992): Ramselaar CG+, Br J Urol 70, 451 (1985): Cheung J+, Anaesth Intensive Care 13, 429 (1982): Staab W+, Stomatol DDR (German) 32, 700 Dermatitis (2007): Kaminska R+, Contact Dermatitis 56(6), 358 (contact) (2001): Barnett L+, Ostomy Wound Manage 47(9), 47 (2001): Barrazza V, Contact Dermatitis 45(1), 42 (1998): Ebo DG+, J Allergy Clin Immunol 101, 128 (1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 18, 3295 (1995): Stingeni L+, Contact Dermatitis 33, 172 (1990): Reynolds NJ+, Contact Dermatitis 22, 103 (1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84 (1987): Osmundsen PE+, Ugeskr Laeger (Danish) 149, 3048 (1985): Lasthein Andersen B+, Contact Dermatitis 13, 307 (5.4%) (1983): Shoji A, Contact Dermatitis 9, 156 (1982): Osmundsen PE, Contact Dermatitis 8, 81 (1981): Roberts DL+, Contact Dermatitis 7, 326 Facial edema (10%) Vaginal pruritus (2004): Wilson CM+, J Acquir Immune Defic Syndr 35(2), 138 Other Anaphylactoid reactions/Anaphylaxis (2004): Beaudouin E+, Allerg Immunol (Paris) 36(4), 123 (2004): Krautheim AB+, Contact Dermatitis 50(3), 113 (2001): Garvey LH+, Acta Anaesthesiol Scand 45(10), 1204 (4 cases) (2001): Knight BA+, Intern Med J 31(7), 436 (2001): Lockhart AS+, Br J Anaesth 87(6), 940 (2001): Stephens R+, Br J Anaesth 87(2), 306 (with sulfadiazine) (2000): Pham NH+, Clin Exp Allergy 30, 1001 (1999): Autegarden JE+, Contact Dermatitis 40, 215 (1999): Snellman E+, JAmAcadDermatol40, 771 (1998): Ebo DG+, J Allergy Clin Immunol 101, 128 (1998): Nikaido S+, Masui (Japanese) 47, 330 (1998): Olivieri J+, Schweiz Med Wochenschr 128, 1508 (1998): Terazawa E+, Anesthesiology 89, 1296 (1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 118, 3295 (1997): Chisholm DG+, BMJ 315, 785 (1997): Fujita S+, Masui (Japanese) 46, 1118 (2 cases) (1996): Torricelli R, Clin Exp Allergy 26, 112 (1995): Parker F+, Anaesth Intensive Care 23, 126 (1994): de Groot AC+, Ned Tijdschr Geneeskd (Dutch) 138, 1342 (1994): Okuda T+, Masui (Japanese) 43, 1352 (1994): Russ BR+, Anaesth Intensive Care 22, 611 (1994): Visser LE+, Ned Tijdschr Geneeskd (Dutch) 138, 778 (1992): Evans RJ, BMJ 304, 686 (1992): Harukuni I+, Masui (Japanese) 41, 455 (1992): Peutrell JM, Anaesthesia 47, 1013 (1990): Wong WK+, Contact Dermatitis 22, 52 Hypersensitivity (2001): Lauerma AL, Contact Dermatitis 44(1), 59 (1998): Burlington B, Ostomy Wound Manage 44, 84 (1994): Aalto-Korte K+, Duodecim (Finnish) 110, 2013 (1989): Okano M+, Arch Dermatol 125, 50 (6 cases) (1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84 (1986): Ohtoshi T+, Clin Allergy 16, 155 (1986): Yaacob H+, JOralMed41, 145 CHLORMEZANONE Trade name: Trancopal Indications: Anxiety Category: Anxiolytic; Central muscle relaxant Half-life: 24 hours Reactions CHLORMEZANONE 117 Skin Edema Erythema multiforme Exanthems (1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223 Fixed eruption (1998): Leal G, Fortaleza, Brazil (from Internet) (observation) (1998): Lee AY, Contact Dermatitis 38(5), 258 (1998): Mahboob A+, Int J Dermatol 37, 833 (1995): Rademacher D+, Contact Dermatitis 32, 117 (1992): el-Sayed F+, Ann Dermatol Venereol (French) 119, 671 (1991): Lee AY+, Drug Intell Clin Pharm 25, 604 (1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223 (1988): McFadden N, Dermatologica 176, 106 (1985): Kauppinen K+, Br J Dermatol 112, 575 (1985): Verbov J, Dermatologica 171, 60 (with acetaminophen) (1983): Mohamed KN+, Int J Dermatol 22, 548 Peripheral edema Pruritus Rash (sic) (1991): Lee AY+, Drug Intell Clin Pharm 25, 604 (passim) Stevens–Johnson syndrome (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1995): Wolkenstein P+, Drug Saf 13, 56 Toxic epidermal necrolysis (1998): von Boxberg C+, Dtsch Med Wochenschr (German) 123, 866 (fatal) (1996): Blum L+, JAmAcadDermatol34, 1088 (1995): Roujeau JC+, NEnglJMed333(24), 1600 (1993): Correia O+, Dermatology 186, 32 (1992): Saiag P+, JAmAcadDermatol26, 567 (1991): Rosenthal E+, Presse Med (French) 20, 1459 (1987): Guillaume JC+, Arch Dermatol 123, 1166 (1983): Tagami H+, Arch Dermatol 119, 910 Urticaria Mucosal Xerostomia
118 CHLORMEZANONE Other Death CHLOROQUINE Trade names: Aralen (Sanofi-Aventis); Avloclor; Chlorquin; Emquin; Heliopar; Lagaquin; Malarivon Indications: Malaria, rheumatoid arthritis, lupus erythematosus Category: Antimalarial; Antiprotozoal; Disease-modifying antirheumatic Half-life: 3–5 days Clinically important, potentially hazardous interactions with: acitretin, antacids, cholestyramine, dapsone, furazolidone, hydroxychloroquine, methotrexate, methoxsalen, penicillamine, sulfonamides Reactions Skin Acute generalized exanthematous pustulosis (AGEP) (1998): Janier M+, Dermatology 196, 271 Angioedema (
- Page 142 and 143: (2000): Bedikian AY+, Oncol Rep 7,
- Page 144 and 145: BISMUTH Trade names: Bismatrol; Bis
- Page 146 and 147: BLEOMYCIN Synonyms: bleo; BLM Trade
- Page 148 and 149: BLOODROOT Scientific name: Sanguina
- Page 150 and 151: Punctate keratitis (2004): Northing
- Page 152 and 153: BROMFENAC Trade name: Xibrom (ISTA
- Page 154 and 155: Erythema multiforme (
- Page 156 and 157: Myalgia/Myositis/Myopathy/Myotoxici
- Page 158 and 159: (1989): Ackerman WE+, Can J Anaesth
- Page 160 and 161: CALFACTANT Trade name: Infasurf (Fo
- Page 162 and 163: CAPSICUM Scientific names: Capsicum
- Page 164 and 165: Lupus erythematosus (2002): Ratliff
- Page 166 and 167: Corneal edema Eyelid twitching Kera
- Page 168 and 169: Stevens-Johnson syndrome (1-10%) (2
- Page 170 and 171: Porphyria variegata (2001): Grieco
- Page 172 and 173: (1983): Rollings HE+, Curr Ther Res
- Page 174 and 175: Dermatitis (1986): Hirata M+, Kokyu
- Page 176 and 177: Other Anaphylactoid reactions/Anaph
- Page 178 and 179: Other Anaphylactoid reactions/Anaph
- Page 180 and 181: Other Anaphylactoid reactions/Anaph
- Page 182 and 183: Candidiasis (
- Page 184 and 185: Herpes zoster (
- Page 186 and 187: Hypersensitivity Injection-site pai
- Page 188 and 189: Other Abdominal pain (25%) Anaphyla
- Page 190 and 191: CHLORAMBUCIL Trade names: Chloramin
- Page 194 and 195: (1997): Selvaag E, Ann Trop Pediatr
- Page 196 and 197: (1989): Rosen C, Semin Dermatol 8,
- Page 198 and 199: CHOLESTYRAMINE Trade names: Chol-Le
- Page 200 and 201: CIMETIDINE Trade names: Apo-Cimetid
- Page 202 and 203: (2000): Sharobeem KM+, J Cardiovasc
- Page 204 and 205: (1997): Carrasco JM+, Ann Pharmacot
- Page 206 and 207: CITALOPRAM Synonym: nitalapram Trad
- Page 208 and 209: CLEMASTINE Trade names: Aller-Eze;
- Page 210 and 211: Other Hypersensitivity (2002): Somm
- Page 212 and 213: CLOMIPRAMINE Trade names: Anafranil
- Page 214 and 215: CLOPIDOGREL Trade name: Plavix (Bri
- Page 216 and 217: Eczema (
- Page 218 and 219: (1997): Thaler D, Monona, WI (from
- Page 220 and 221: COCOA Scientific names: Theobroma c
- Page 222 and 223: COLESEVELAM Trade name: Welchol (Sa
- Page 224 and 225: CORDYCEPS Scientific name: Cordycep
- Page 226 and 227: CYCLAMATE Trade name: Sucaryl (Abbo
- Page 228 and 229: Inappropriate secretion of antidiur
- Page 230 and 231: (1996): Cox NH, Clin Exp Dermatol 2
- Page 232 and 233: (2007): Lim AK+, Intern Med J 37(1)
- Page 234 and 235: (1989): Kerker BJ+, Semin Dermatol
- Page 236 and 237: Pruritus (1-10%) Rash (sic) (1-10%)
- Page 238 and 239: (1988): Tham SN+, Singapore Med J 2
- Page 240 and 241: DASATINIB Synonym: BMS354825 Trade
(1992): Ramselaar CG+, Br J Urol 70, 451<br />
(1985): Cheung J+, Anaesth Intensive Care 13, 429<br />
(1982): Staab W+, Stomatol DDR (German) 32, 700<br />
Dermatitis<br />
(2007): Kaminska R+, Contact Dermatitis 56(6), 358 (contact)<br />
(2001): Barnett L+, Ostomy Wound Manage 47(9), 47<br />
(2001): Barrazza V, Contact Dermatitis 45(1), 42<br />
(1998): Ebo DG+, J Allergy Clin Immunol 101, 128<br />
(1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 18, 3295<br />
(1995): Stingeni L+, Contact Dermatitis 33, 172<br />
(1990): Reynolds NJ+, Contact Dermatitis 22, 103<br />
(1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84<br />
(1987): Osmundsen PE+, Ugeskr Laeger (Danish) 149, 3048<br />
(1985): Lasthein Andersen B+, Contact Dermatitis 13, 307<br />
(5.4%)<br />
(1983): Shoji A, Contact Dermatitis 9, 156<br />
(1982): Osmundsen PE, Contact Dermatitis 8, 81<br />
(1981): Roberts DL+, Contact Dermatitis 7, 326<br />
Facial edema (10%)<br />
Vaginal pruritus<br />
(2004): Wilson CM+, J Acquir Immune Defic Syndr 35(2), 138<br />
Other<br />
Anaphylactoid reactions/Anaphylaxis<br />
(2004): Beaudouin E+, Allerg Immunol (Paris) 36(4), 123<br />
(2004): Krautheim AB+, Contact Dermatitis 50(3), 113<br />
(2001): Garvey LH+, Acta Anaesthesiol Sc<strong>and</strong> 45(10), 1204 (4<br />
cases)<br />
(2001): Knight BA+, Intern Med J 31(7), 436<br />
(2001): Lockhart AS+, Br J Anaesth 87(6), 940<br />
(2001): Stephens R+, Br J Anaesth 87(2), 306 (with sulfadiazine)<br />
(2000): Pham NH+, Clin Exp Allergy 30, 1001<br />
(1999): Autegarden JE+, Contact Dermatitis 40, 215<br />
(1999): Snellman E+, JAmAcadDermatol40, 771<br />
(1998): Ebo DG+, J Allergy Clin Immunol 101, 128<br />
(1998): Nikaido S+, Masui (Japanese) 47, 330<br />
(1998): Olivieri J+, Schweiz Med Wochenschr 128, 1508<br />
(1998): Terazawa E+, Anesthesiology 89, 1296<br />
(1998): Thune P, Tidsskr Nor Laegeforen (Norwegian) 118, 3295<br />
(1997): Chisholm DG+, BMJ 315, 785<br />
(1997): Fujita S+, Masui (Japanese) 46, 1118 (2 cases)<br />
(1996): Torricelli R, Clin Exp Allergy 26, 112<br />
(1995): Parker F+, Anaesth Intensive Care 23, 126<br />
(1994): de Groot AC+, Ned Tijdschr Geneeskd (Dutch)<br />
138, 1342<br />
(1994): Okuda T+, Masui (Japanese) 43, 1352<br />
(1994): Russ BR+, Anaesth Intensive Care 22, 611<br />
(1994): Visser LE+, Ned Tijdschr Geneeskd (Dutch) 138, 778<br />
(1992): Evans RJ, BMJ 304, 686<br />
(1992): Harukuni I+, Masui (Japanese) 41, 455<br />
(1992): Peutrell JM, Anaesthesia 47, 1013<br />
(1990): Wong WK+, Contact Dermatitis 22, 52<br />
Hypersensitivity<br />
(2001): Lauerma AL, Contact Dermatitis 44(1), 59<br />
(1998): Burlington B, Ostomy Wound Manage 44, 84<br />
(1994): Aalto-Korte K+, Duodecim (Finnish) 110, 2013<br />
(1989): Okano M+, Arch Dermatol 125, 50 (6 cases)<br />
(1988): Bergqvist-Karlsson A, Contact Dermatitis 18, 84<br />
(1986): Ohtoshi T+, Clin Allergy 16, 155<br />
(1986): Yaacob H+, JOralMed41, 145<br />
CHLORMEZANONE<br />
Trade name: Trancopal<br />
Indications: Anxiety<br />
Category: Anxiolytic; Central muscle relaxant<br />
Half-life: 24 hours<br />
Reactions<br />
CHLORMEZANONE 117<br />
Skin<br />
Edema<br />
Erythema multiforme<br />
Exanthems<br />
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223<br />
Fixed eruption<br />
(1998): Leal G, Fortaleza, Brazil (from Internet) (observation)<br />
(1998): Lee AY, Contact Dermatitis 38(5), 258<br />
(1998): Mahboob A+, Int J Dermatol 37, 833<br />
(1995): Rademacher D+, Contact Dermatitis 32, 117<br />
(1992): el-Sayed F+, Ann Dermatol Venereol (French) 119, 671<br />
(1991): Lee AY+, <strong>Drug</strong> Intell Clin Pharm 25, 604<br />
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223<br />
(1988): McFadden N, Dermatologica 176, 106<br />
(1985): Kauppinen K+, Br J Dermatol 112, 575<br />
(1985): Verbov J, Dermatologica 171, 60 (with acetaminophen)<br />
(1983): Mohamed KN+, Int J Dermatol 22, 548<br />
Peripheral edema<br />
Pruritus<br />
Rash (sic)<br />
(1991): Lee AY+, <strong>Drug</strong> Intell Clin Pharm 25, 604 (passim)<br />
Stevens–Johnson syndrome<br />
(1995): Roujeau JC+, NEnglJMed333(24), 1600<br />
(1995): Wolkenstein P+, <strong>Drug</strong> Saf 13, 56<br />
Toxic epidermal necrolysis<br />
(1998): von Boxberg C+, Dtsch Med Wochenschr (German)<br />
123, 866 (fatal)<br />
(1996): Blum L+, JAmAcadDermatol34, 1088<br />
(1995): Roujeau JC+, NEnglJMed333(24), 1600<br />
(1993): Correia O+, Dermatology 186, 32<br />
(1992): Saiag P+, JAmAcadDermatol26, 567<br />
(1991): Rosenthal E+, Presse Med (French) 20, 1459<br />
(1987): Guillaume JC+, Arch Dermatol 123, 1166<br />
(1983): Tagami H+, Arch Dermatol 119, 910<br />
Urticaria<br />
Mucosal<br />
Xerostomia